文献速递泌尿生殖技术与安全US

低强度脉冲超声调节Th17/Treg平衡,可能与IL-1β/IL1R1/MyD88信号通路相关,从而缓解大鼠前列腺炎模型的盆腔疼痛

Low-Intensity Pulsed Ultrasound Regulates Th17/Treg Balance With Potential Association With the IL-1β/IL1R1/MyD88 Signaling Pathway to Alleviate Pelvic Pain in a Rat Prostatitis Model.
PubMed 文献 · Ultrasound Med Biol · 2025-11-20

本研究在大鼠前列腺炎模型上比较三种强度(0.5、1.0、1.5 W/cm²)和两种疗程(2或4周)的低强度脉冲超声(LIPUS)治疗效果,发现1.0 W/cm²作用4周缓解盆腔疼痛和降低前列腺炎症评分最明显,并伴随Th17/Treg平衡调节及IL-1β、IL1R1、MyD88表达下调。

要点

  • 动物模型中1.0 W/cm²、4周方案缓解盆腔疼痛和降低前列腺炎症评分最明显
  • LIPUS治疗后前列腺组织IL-1β、IL1R1、MyD88表达下调
  • 机制涉及调节Th17/Treg平衡, Foxp3与IL-17A表达及CD4+ T细胞被检测

核心结论

  • 1.0 W/cm²、4周的LIPUS在大鼠CP/CPPS模型中缓解疼痛效果最优,并可能通过调节Th17/Treg平衡及下调IL-1β/IL1R1/MyD88通路发挥作用。

研究设计与样本

  • 大鼠CP/CPPS模型研究:向前列腺注射1%角叉菜胶建模,LIPUS设T1、T2、T3三组强度(分别为0.5、1.0、1.5 W/cm²),每日照射盆腔区域10分钟,疗程2或4周。

诊断标准与关键数值

  • 与模型组相比,1.0 W/cm²/4周组显著缓解盆腔疼痛并降低前列腺炎症评分;该组Th17/Treg平衡被调节,IL-1β、IL1R1、MyD88表达下调;CD4+ T细胞经流式细胞术检测,Foxp3/IL-17A经免疫组化检测,通路蛋白经Western blot检测,炎症因子经酶联免疫吸附试验测定。

临床应用与阅片要点

  • 作者认为LIPUS可能为CP/CPPS提供一种有前景的治疗方法,并对其作用机制提供线索。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a common urinary tract disorder in males. Low-intensity pulsed ultrasound (LIPUS), a non-invasive therapeutic modality, has shown potential in alleviating inflammation associated with this condition. However, the underlying mechanisms through which LIPUS exerts its effects on CP/CPPS remain largely unknown. This study aimed to investigate the impact of LIPUS at varying intensities and durations on pain relief in a rat model of CP/CPPS.

METHODS: A CP/CPPS model was established by injecting 1% carrageenan into the prostate of rats. LIPUS at three different energy intensities (T1, T2 and T3: 0.5, 1.0 and 1.5 W/cm², respectively) was applied to the pelvic region for 10 min daily over a period of 2 or 4 weeks. Pain relief and prostate injury were evaluated to assess the therapeutic efficacy of LIPUS. The mechanism study focuses on the role of LIPUS in regulating the Th17/Treg balance (by detecting CD4+ T cells in the prostate through flow cytometry and the expression of Foxp3/interleukin-17A (IL-17A) in prostate tissue through immunohistochemistry) as well as its effects on the IL-1β/IL1R1/MyD88 signaling pathway in prostate tissue (by detecting pathway protein expression through Western blot and measuring inflammatory factor concentration using enzyme-linked immunosorbent assay).

RESULTS: To identify the optimal parameter of LIPUS for CP/CPPS, we treated model rats with LIPUS at intensities of 0.5, 1.0 or 1.5 W/cm² for 2 or 4 weeks, and evaluated the therapeutic effects using multiple endpoints. Among these intensities, LIPUS at 1.0 W/cm2 energy/4 weeks exhibited the most prominent efficacy: compared with the model group, it significantly alleviated pelvic pain and reduced prostate inflammation scores. Further mechanistic studies demonstrated that, relative to the model group, LIPUS at 1.0 W/cm2 energy/4 weeks could regulate Th17/Treg balance and downregulate the expression of related proteins, including IL-1β, IL1R1 and MyD88.

CONCLUSION: LIPUS, when administered at 1.0 W/cm² for 4 weeks, showed superior efficacy in reducing pain in CP/CPPS rats. These findings suggest that LIPUS may offer a promising therapeutic approach for CP/CPPS and provide insights into its underlying mechanism of action.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Zhou W, Du HX, Wang ZC, et al. Low-Intensity Pulsed Ultrasound Regulates Th17/Treg Balance With Potential Association With the IL-1β/IL1R1/MyD88 Signaling Pathway to Alleviate Pelvic Pain in a Rat Prostatitis Model. Ultrasound Med Biol. 2025. PMID: 41271486. doi:10.1016/j.ultrasmedbio.2025.10.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。